What are the listed companies that produce Fabravi?

Fabiravir, formerly known as Fabiravir, is a broad-spectrum anti-influenza drug and has been sold overseas. Recently, Fabiravi went public in China. Next, Bian Xiao will introduce the listed companies that produce Fabiravir.

It is reported that Farpinavir was developed by Toyama Chemical Co., Ltd. In 20 16, Haizheng Pharmaceutical signed an exclusive license agreement for compound patents with this company. On February 15, 2020, Puravet passed the examination of the State Administration of Medical Products. On February 16, Haizheng Pharmaceutical organized employees to produce.

According to reports, Fabiravir is expected to be officially released in late February. Affected by the above news, Haizheng Pharmaceutical ushered in a continuous rise. By the close of February 18, Haizheng Pharmaceutical's share price was 17.73 yuan, up by 3.26%, and its market value was17/190,000. Judging from the current situation,